It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Exo Therapeutics logo

Exo Therapeutics 

Aaron Nelson - Director 
Michelle Ma - Observer

Oncology, Platform 
Boston, USA 

Exo Therapeutics is developing small-molecule enzyme inhibitors that target distal binding pockets to reprogram enzyme activity with a focus on high-value oncology indications.